{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Corti S"],"funding":["Telethon"],"pagination":["165ra162"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4722730"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["4(165)"],"pubmed_abstract":["Spinal muscular atrophy (SMA) is among the most common genetic neurological diseases that cause infant mortality. Induced pluripotent stem cells (iPSCs) generated from skin fibroblasts from SMA patients and genetically corrected have been proposed to be useful for autologous cell therapy. We generated iPSCs from SMA patients (SMA-iPSCs) using nonviral, nonintegrating episomal vectors and used a targeted gene correction approach based on single-stranded oligonucleotides to convert the survival motor neuron 2 (SMN2) gene into an SMN1-like gene. Corrected iPSC lines contained no exogenous sequences. Motor neurons formed by differentiation of uncorrected SMA-iPSCs reproduced disease-specific features. These features were ameliorated in motor neurons derived from genetically corrected SMA-iPSCs"],"journal":["Science translational medicine"],"pubmed_title":["Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy."],"pmcid":["PMC4722730"],"funding_grant_id":["GGP10062","GGP09107"],"pubmed_authors":["Riboldi G","Salani S","Rizzo F","Menozzi G","Corti S","Donadoni C","Falcone M","Simone C","Nizzardo M","Magri F","Bresolin N","Ronchi D","Comi GP","Nardini M","Bonaglia C"],"additional_accession":[]},"is_claimable":false,"name":"Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy.","description":"Spinal muscular atrophy (SMA) is among the most common genetic neurological diseases that cause infant mortality. Induced pluripotent stem cells (iPSCs) generated from skin fibroblasts from SMA patients and genetically corrected have been proposed to be useful for autologous cell therapy. We generated iPSCs from SMA patients (SMA-iPSCs) using nonviral, nonintegrating episomal vectors and used a targeted gene correction approach based on single-stranded oligonucleotides to convert the survival motor neuron 2 (SMN2) gene into an SMN1-like gene. Corrected iPSC lines contained no exogenous sequences. Motor neurons formed by differentiation of uncorrected SMA-iPSCs reproduced disease-specific features. These features were ameliorated in motor neurons derived from genetically corrected SMA-iPSCs","dates":{"release":"2012-01-01T00:00:00Z","publication":"2012 Dec","modification":"2026-05-05T13:07:46.944Z","creation":"2026-04-27T03:08:28.482Z"},"accession":"S-EPMC4722730","cross_references":{"pubmed":["23253609"],"doi":["10.1126/scitranslmed.3004108"]}}